Bh3 interacting domain death agonist

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/02 (2006.01) A61K 38/00 (2006.01) A61K 48/00 (2006.01) C07H 21/04 (2006.01) C07K 14/00 (2006.01) C07K 14/47 (2006.01) C07K 16/00 (2006.01) C12N 5/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2264578

A novel death agonist, BID, which contains only a BH3 domain but not the BH1, BH2, BH4 or membrane anchoring domains found in related BCL-2 family members is provided along with derivatives of BID, bid polynucleotides and derivatives thereof and compositions and uses therefor.

L'invention concerne un nouvel agoniste de mort, BID, lequel ne ocontient qu'un domaine BH3 et non les domaines BH1, BH2, BH4 ou de fixation sur membrane rencontrés dans les membres apparentés de la famille BCL-2, ainsi que des dérivés BID, ces polynucléotides bid et dérivés de ceux-ci ainsi que des compositions les contenant et leurs utilisations.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bh3 interacting domain death agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bh3 interacting domain death agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bh3 interacting domain death agonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1621693

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.